Kalaris Therapeutics, Inc. (KLRS)
6.10
-0.23
(-3.63%)
USD |
NASDAQ |
Apr 23, 16:00
6.05
-0.05
(-0.82%)
After-Hours: 20:00
Kalaris Therapeutics Total Assets (Quarterly) : 121.74M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.564B |
| Agenus, Inc. | 226.80M |
| Alnylam Pharmaceuticals, Inc. | 5.026B |
| Savara, Inc. | 253.44M |
| Arrowhead Pharmaceuticals, Inc. | 1.604B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 42.92M |
| Shareholders Equity (Quarterly) | 78.81M |
| Debt to Equity Ratio | 0.0184 |
| Current Ratio | 12.23 |
| Net Debt Paydown Yield | -0.15% |